XML 23 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 02, 2016
Jan. 03, 2015
Dec. 28, 2013
Operating Activities      
Net Income Attributable to Kadant $ 34,389 $ 28,659 $ 23,419
Net income attributable to noncontrolling interest 294 389 229
(Income) loss from discontinued operation (74) 23 62
Income from continuing operations 34,609 29,071 23,710
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:      
Depreciation and amortization 10,821 11,189 9,775
Stock-based compensation expense 5,741 5,813 5,216
Tax benefits from stock-based compensation awards (881) (771) (351)
Loss (gain) on sale of property, plant and equipment 4 (118) (2,012)
Provision for losses on accounts receivable 379 246 374
Deferred income tax (benefit) provision (1,706) 2,951 (1,061)
Other items, net (287) 1,318 1,836
Contributions to pension plan (1,080) (1,080) (1,080)
Changes in current assets and liabilities, net of effects of acquisitions:      
Accounts receivable (10,640) 8,429 (2,197)
Unbilled contract costs and fees (1,534) (2,277) (840)
Inventories (6,486) 5,067 (2,005)
Other current assets 1,495 (563) 113
Accounts payable (1,752) 652 2,552
Other current liabilities 9,228 (11,060) 5,905
Net cash provided by continuing operations 37,911 48,867 39,935
Net cash (used in) provided by discontinued operation (38) 5 141
Net cash provided by operating activities 37,873 48,872 40,076
Investing Activities      
Acquisitions, net of cash acquired 0 (11,984) (65,594)
Purchases of property, plant, and equipment (5,479) (6,755) (6,261)
Proceeds from sale of property, plant, and equipment 30 242 3,459
Dividend paid to noncontrolling interest 0 0 (731)
Other, net 0 0 971
Net cash used in continuing operations for investing activities (5,449) (18,497) (68,156)
Financing Activities      
Proceeds from issuance of short- and long-term obligations 24,000 24,512 53,609
Repayments of short- and long-term obligations (18,611) (36,953) (21,849)
Purchases of Company common stock (9,906) (15,136) (5,367)
Dividends paid (7,179) (6,339) (4,189)
Change in restricted cash (1,066) (299) (168)
Payment of debt issuance costs 0 0 (154)
Proceeds from issuance of Company common stock 754 1,119 337
Tax benefits from stock-based compensation awards 881 771 351
Net cash (used in) provided by continuing operations for financing activities (11,127) (32,325) 22,570
Exchange Rate Effect on Cash and Cash Equivalents from Continuing Operations (1,145) (2,704) 989
Increase (Decrease) in Cash and Cash Equivalents from Continuing Operations 20,152 (4,654) (4,521)
Cash and Cash Equivalents at Beginning of Year 45,378 50,032 54,553
Cash and Cash Equivalents at End of Year $ 65,530 $ 45,378 $ 50,032